Cherry Jonathan D, Zeineddin Ahmad, Dammer Eric B, Webster James A, Duong Duc, Seyfried Nicholas T, Levey Allan I, Alvarez Victor E, Huber Bertrand R, Stein Thor D, Kiernan Patrick T, McKee Ann C, Lah James J, Hales Chadwick M
Boston University Alzheimer's Disease and CTE Center; Department of Neurology, Boston University School of Medicine, Boston, Massachusetts; Center for Neurodegenerative Disease, Emory University School of Medicine; Department of Biochemistry, Emory University School of Medicine; Department of Neurology, Emory University School of Medicine, Atlanta, Georgia; Department of Anatomy and Neurobiology; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts; VA Boston Healthcare System, Boston, Massachusetts; and Department of Veterans Affairs Medical Center, Bedford, Massachusetts.
J Neuropathol Exp Neurol. 2018 Jan 1;77(1):40-49. doi: 10.1093/jnen/nlx100.
Quantitative proteomics of postmortem human brain can identify dysfunctional proteins that contribute to neurodegenerative disorders like Alzheimer disease (AD) and frontotemporal dementia. Similar studies in chronic traumatic encephalopathy (CTE) are limited, therefore we hypothesized that proteomic sequencing of CTE frontal cortex brain homogenates from varying CTE pathologic stages may provide important new insights into this disorder. Quantitative proteomics of control, CTE and AD brains was performed to characterize differentially expressed proteins, and we identified over 4000 proteins in CTE brains, including significant enrichment of the microtubule associated protein tau. We also found enrichment and pathologic aggregation of RNA processing factors as seen previously in AD, supporting the previously recognized overlap between AD and CTE. In addition to these similarities, we identified CTE-specific enrichment of proteins which increase with increasing severity of CTE pathology. NADPH dehydrogenase quinone 1 (NQO1) was one of the proteins which showed significant enrichment in CTE and also correlated with increasing CTE stage. NQO1 demonstrated neuropathologic correlation with hyperphosphorylated tau in glial cells, mainly astrocytes. These results demonstrate that quantitative proteomic analysis of CTE postmortem human brain can identify disease relevant findings and novel cellular pathways involved in CTE pathogenesis.
对死后人类大脑进行定量蛋白质组学分析,可以识别出导致神经退行性疾病(如阿尔茨海默病(AD)和额颞叶痴呆)的功能失调蛋白质。在慢性创伤性脑病(CTE)方面的类似研究有限,因此我们推测,对处于不同CTE病理阶段的CTE额叶皮质脑匀浆进行蛋白质组测序,可能会为这种疾病提供重要的新见解。对对照、CTE和AD大脑进行定量蛋白质组学分析,以表征差异表达的蛋白质,我们在CTE大脑中鉴定出4000多种蛋白质,包括微管相关蛋白tau的显著富集。我们还发现RNA加工因子的富集和病理聚集,这与之前在AD中观察到的情况一致,支持了之前认识到的AD和CTE之间的重叠。除了这些相似之处,我们还鉴定出随着CTE病理严重程度增加而富集的CTE特异性蛋白质。NADPH脱氢酶醌1(NQO1)是在CTE中显著富集且与CTE阶段增加相关的蛋白质之一。NQO1在神经病理学上与神经胶质细胞(主要是星形胶质细胞)中过度磷酸化的tau相关。这些结果表明,对CTE死后人类大脑进行定量蛋白质组学分析,可以识别与疾病相关的发现以及参与CTE发病机制的新细胞途径。